Hospitals and affiliated cardiovascular professionals participating in ACC's NCDR registries can take advantage of the following resources to help meet certain requirements under the federal Quality Payment Program (QPP).
Learn more about the program and check your participation status via the official Centers for Medicare and Medicaid Services (CMS) QPP website.
Don't MIPS Out!
The Merit-Based Incentive Payment System (MIPS) is one way to participate in the QPP and there are currently three MIPS reporting options available: 1) Traditional MIPS; 2) Alternative Payment Model (APM) Performance Pathway; and 3) MIPS Value Pathways (MVPs).
The ACC's Professional Data Portfolio App counts as an Improvement Activity under the Traditional MIPS option.
Learn more about MIPS reporting options and specific requirements on the CMS website. The 2024 MIPS quick start guide is also available for download.
Note: You can now sign in to submit and review your data for the 2023 performance year. You can submit and update your data any time until April 1, 2024 at 8 p.m. ET when the submission window closes. More details are available on the CMS QPP website.
Advanced APMs
The CMS Bundled Payments for Care Improvement (BPCI) Advanced program qualifies as an advanced alternative payment (APM) model under the QPP. BPCI Advanced clinicians who voluntarily participate in this model and meet relevant payment or patient thresholds can also qualify for the Advanced APM bonus and be exempt from MIPS.
Several ACC registry-based quality measures are part of BPCI Advanced, including:
- Defect Free Care for Myocardial Infarction (AMI) - NQF #2377 (PDF)
- Discharge Medications (Angiotensin-Converting Enzyme / Angiotensin Receptor Blocker and Beta Blockers) in Eligible Implantable Cardiac Defibrillator/Cardiac Resynchronization Therapy Defibrillators Implant Patients (NQF #0965)
- Hospital Risk-Standardized Complication Rate following Implantation of Implantable Cardioverter-Defibrillator (ICD) Composite Measure
- In-Person Evaluation Following Implantation of a Cardiovascular Implantable Electronic Device (CIED) (NQF #2461)
- Risk Standardized Bleeding for Patients Undergoing Percutaneous Coronary Intervention (PCI) (NQF #2459)
- Therapy with Aspirin, P2Y12 Inhibitor, and Statin at Discharge Following Percutaneous Coronary Intervention in Eligible Patients (NQF #0964)
Learn more about the program and access the most recent updates and participation requirements on the CMS Innovation Center website. For more information on Model Year 6 (2023) changes and extensions, go here.
*Note: BPCI Advanced enrollees who also participate in one or more of the ACC's NCDR data registries, or who are affiliated with an NCDR participating facility, can have the respective NCDR Registry complete the BPCI Advanced data reporting requirement on their behalf. For this to happen, any model enrollees who are active in or applying to the BPCI Advanced in Model Year 7 (2024) must submit to CMS their intent to use Alternate Quality Measures from ACC NCDR's registries. A complete list of NCDR participating facilities can be found though searching the Find Your Heart a Home webpage. Learn more about the current BPCI Advanced enrollment period and access additional resources.
ACC Resources
CathPCI Registry Data Release Consent Form
Chest Pain – MI Registry Data Release Consent Form
EP Device Implant Registry Data Release Consent Form
BPCI Advanced Alternative Quality Measures – CathPCI Registry [PPTX]
BPCI Advanced Alternative Quality Measures – Chest Pain – MI Registry [PPTX]
BPCI Advanced Alternative Quality Measures – EP Device Implant Registry [PPTX]
Webinar: Value Based Purchasing Update: Registry Options for CMS BPCI Advanced [Video]